Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.

Biotechnology

Raqia Therapeutics

Raqia Therapeutics' headquarters in Boston, MA, United States

Fred Mermelstein

Alberto Nobili

Julia A. Novina

Nikhil Munshi

Marc A. Cohen

Carl Novina

Kenneth Anderson

Alain Cohen

Steven Neier

Drew Dennison

Malcolm Salter

Bruce Evans

Research and Development

Leadership Team

Raqia Therapeutics

Org chart

Board & advisors

Teams

Research and Development

Leadership Team

Offices

Similar companies